MedPath
TGA Approval

ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablets blister pack (446592)

446592

ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablets blister pack

Mundipharma Pty Ltd

October 8, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-CMI-01374-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-02715-1

Active Ingredients

naloxone hydrochloride dihydrate

oxycodone hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ARX-Oxycodone/Naloxone oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablets blister pack (446592) - TGA 批准文号 | MedPath